Xiucai Liu - Cathay Biotech Chairman CEO
| 688065 Stock | 42.02 0.48 1.13% |
Chairman
Xiucai Liu is Chairman CEO of Cathay Biotech
| Age | 67 |
| Address | Lvzhou Ring Road, Shanghai, China |
| Phone | 86 21 5080 1916 |
| Web | https://www.cathaybiotech.com |
Cathay Biotech Management Efficiency
The company has return on total asset (ROA) of 0.0106 % which means that it generated a profit of $0.0106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.026 %, meaning that it generated $0.026 on every $100 dollars invested by stockholders. Cathay Biotech's management efficiency ratios could be used to measure how well Cathay Biotech manages its routine affairs as well as how well it operates its assets and liabilities. At present, Cathay Biotech's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 8.5 B, whereas Total Assets are forecasted to decline to about 15.6 B.Similar Executives
| Found 5 records | CHAIRMAN Age | ||
| Zhanbing Zhao | Xinya Electronic Co | 56 | |
| Tianming Liu | Sihui Fuji Electronics | N/A | |
| Biao Liu | Shenzhen Clou Electronics | 51 | |
| Zeng Yong | LianChuang Electronic Technolog | 60 | |
| Dao Ma | Unigroup Guoxin Microelectronic | 60 | |
Management Performance
| Return On Equity | 0.026 | ||||
| Return On Asset | 0.0106 |
Cathay Biotech Leadership Team
Elected by the shareholders, the Cathay Biotech's board of directors comprises two types of representatives: Cathay Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cathay. The board's role is to monitor Cathay Biotech's management team and ensure that shareholders' interests are well served. Cathay Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cathay Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yijun Du, Vice President | ||
| Chen Yang, Core VP | ||
| Joachim Rudolf, CFO Director | ||
| Huiqing Zang, Secretary President | ||
| Hong Zhang, Vice President | ||
| Xiucai Liu, Chairman CEO |
Cathay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cathay Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.026 | ||||
| Return On Asset | 0.0106 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 21.45 B | ||||
| Shares Outstanding | 583.38 M | ||||
| Shares Owned By Insiders | 61.34 % | ||||
| Shares Owned By Institutions | 11.09 % | ||||
| Price To Book | 2.18 X | ||||
| Price To Sales | 8.87 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Cathay Stock
Cathay Biotech financial ratios help investors to determine whether Cathay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cathay with respect to the benefits of owning Cathay Biotech security.